Overview
Patients with clinically and genetically confirmed Gitelman Syndrome are screened for CPPD, and the clinical and radiographic manifestations are collected and analyzed.
Description
Patients with clinically and genetically confirmed Gitelman Syndrome are screened for calcium pyrophosphate deposition, and the clinical data and radiographic manifestations are collected and analyzed to investigate the osteoarticular features in patients with Gitelman Syndrome.
Eligibility
Inclusion Criteria:
- Patients confirmed with Gitelman Syndrome
Exclusion Criteria:
- Patients with other confounding situations such as Bartter Syndrome, hyperparathyroidism